Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
She has been here for a while and has a p&d history dating back many years. Maybe she is looking for redemption now, idk.
Any Day Now!
Thanks for this earlier post TempePhil:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=170667181
Aka p&d George, IMO
Like 99.9% of your posts. Looks like your endless p&d activity isn't working as well as it did around 2016.
Just waiting for your signature "Good Luck and God Bless" before putting you on ignore.
Hey, golly gee. Thank you very much for schooling me in the typical processes in biotechnology. Having worked in the industry for well over two decades, I’m sure I still have a lot to learn.
Blaiming outside forces for the sorry lack of movement toward bringing our product to market is to deny the obvious. Dr Missling has demonstrated outstanding scientific ability but has failed miserably in the role of ceo to bring our product to market. Anyone believing otherwise is, as you would say, woefully naïve.
Listening to the advertisements for cancer drugs and their side effects and the brain swelling/bleeding side effects of the AD drugs and the vomiting/diarrhea side effects of relatively ineffective Rett Syndrome drugs coming on the market, the efforts of the FDA seem more geared toward population control than health care. Missling almost seems part of this wretched game. Sorry. In my younger days, there were times when I had to adjust my demeanor to achieve an objective. WTF. Why does Missling come across as someone that lacks that ability? Time has long since passed to either Lead, Follow or Get Out of the Way. Do something.
Why no bid/ask share price on yahoo. Seems unusual/manipulative?
Very, very unlikely today, IMO. Fasten your seatbelt. We have just now moved to the launch pad.
Word is.getting out that their new drug is an Aduhelm clone. Idk but does anyone have a rational answer why we are not seeking approval for our drug anywhere in the world? If Missling won't do it, why not. Just asking.
Have you ever, ever been dumping this stock while pumping?
“ANAVEX®2-73 (blarcamesine) has previously received Fast Track designation, Rare Pediatric Disease designation and Orphan Drug designation from the FDA for the treatment of Rett syndrome.”
There seems to be a mismatch with the Fast Track Drug designation and the plans our ceo has in response to our stellar results. Is he serious? Missling always talks about being very excited with the results we are getting. Really? “Anavex plans to submit the data for publication in a peer-reviewed medical journal.” Doesn’t sound very exciting. Sounds more and more like a ceo looking for an opportunity to exit left. Just my opinion.
It is becoming increasingly apparent to me that if we ever bring a product to market, Missling will not be our ceo. He is in pretty good stead and will be more so after exercising options. If he is ever forced out as ceo, he will leave a wealthy man. The part of this mornings Rett announcement that caused discomfort was his looking for a journal entry instead of approaching the FDA with these stellar results. All my opinion.
Whoever posted with erronious date needs to be fired, Now!
Is there a biomarker to help determine the best dose to achieve an individual's required baseline? If not, a periodic blood test will be needed to figure it out. Hopefully, the company has smarter people than me to figure it out. This whole Anavex thing has been a real brain teaser, especially in comparison to the other bios bringing their junk to market with the FDA approvals. We need to get our sht together and present it to the FDA. It's either WGT or we DON'T. It's becoming a coin toss for me on some days. I did load up last Thurs or Fri for almost 2600 more shares at $8.20. GLTA.
Someone dumped 66K shares at 9:30 at the 10 cent pop.
Good point. It would seem so. Hopefully, that senerio happens. I try not to put the cart before the horse as many here seem to be doing with this announcement.
I wonder if 2-73 could work for your 'real -credible -unspun sign of belief.' My RCUSOB will only be activated by NDA submission and subsequent FDA approval.
Not saying it was a bad thing. It seems Anavex sought government approval to continue to legally provide 2-73 to trial participants, post-trial. That certainly seems a necessary step to legally do that. I don't read that 2-73 is now available to all Rett Syndrom sufferers without regard to trial participation, unfortunately.
Nothing really new here. All of our clinical trials allow extended use for trial participents. Only for trial participents. Doesn't seem very compassionate to me. All fluff.
Setting us up for a buyout is the only way that somewhat explains our ceo’s missteps over the years. If that is the direction he has been taking us then I must say he is pretty good at it. Releasing several upcoming data sets in close proximity to each other will certainly bring us some attention.
First support $8.35. Second support $8.03
Latest real-time trades:
https://www.nasdaq.com/market-activity/stocks/avxl/latest-real-time-trades
I expect to close out the week in the 7's. It could be the last buying opportunity for believers, IMO.
Get used to it! You won’t be disappointed…Guarenteed.
Why does the announcement text say “ completion of dosing” instead of complete of clinical trial? Maybe it’s my lack of trust in Missling. Maybe no big deal but seems confusing. Idk.
Our CEO on cover Fortune Magazine:
https://finance.yahoo.com/news/fortune-500-record-number-female-100000590.html
Checkered track record would certainly describe a CEO that is focused on bringing a product to market. Right on track would certainly describe a CEO that is getting all the ducks lined up and then not moving forward but stalling, waiting for a take-over bid. We are a small company with a massive portfolio. Small companies like us lack the wherewithal to bring a product to market unless they farm out the manufacturing, packaging and distribution, accepting the risk to quality control. Big Pharma has massive cash reserves but also have some of their big moneymakers coming off patent. Timing is everything. If Missling’s plan is the above, his timing seems to be coming online.
Quarterly Increase/Decrease AVXL holdings:
https://www.holdingschannel.com/holdings-changes/avxl/
“Expose the Criminals”. It seems to be systemic:
https://www.nbcnews.com/health/health-news/fda-broke-protocols-approving-biogen-alzheimers-drug-congressional-rep-rcna63662
The market has many different players with similar financial interests. I know of a company, when they brought their first drug to market, competing with 2 other already commercialized drugs for the same indication, actually got several bomb threats that caused evacuation of it's manufacturing plant. Maybe being embraced by the market is more the exception than the rule. On a positive note, though, the new drug became the most prescribed best seller of the 3. With our multiple indications, it would be nice to have a similar outcome.
Yadda, Yadda, Yadda!
I thought the FDA made some changes that were designed to bring drugs with an urgent need to market sooner. Maybe I'm one of those that doesn't get why a drug with minimal side effects and proven efficacy for various diseases doesn't seem to fit with those FDA changes. Glad Missling won't be the one sitting by the phone if I am in need of a 911 call. Best of luck to all.
Lincoln Park Capital Fund's past performance in the majority of companies that use this vulture fund show a sp decline of 38%. There are two ways to view this, though, as good or bad. Personally, I see this as an upcoming buying opportunity. Our ceo, Drysdale, seems a cut above the rest, IMO.
All of that sounds great. Still have my fingers and toes crossed. Is there a doctor in the house?
Maybe you are right. But I have been here 8 years so patience is not the issue. Could be, as you say, it takes a long time. Or it could be you getting caught up in the insanity yourself. Happy investing. Or maybe happy, happy investing is more appropriate. There is a place for happy, happy people. Maybe this is it,
Insane? The definition of the insanity of continuing with my investment here is me believing we are about to take off when each of our trials produce great results and nothing happens. Then believing Missling wants to get things just right. Thinking this time after time and expecting a different result sounds like insanity to me. I am at some stage of becoming a non-believer. WTF